Pharmaceutical targeting of OTUB2 sensitizes tumors to cytotoxic T cells via degradation of PD-L1.
Ren W, Xu Z, Chang Y, Ju F, Wu H, Liang Z, Zhao M, Wang N, Lin Y, Xu C, Chen S, Rao Y, Lin C, Yang J, Liu P, Zhang J, Huang C, Xia N.
Ren W, et al.
Nat Commun. 2024 Jan 2;15(1):9. doi: 10.1038/s41467-023-44466-7.
Nat Commun. 2024.
PMID: 38167274
Free PMC article.